648
Views
0
CrossRef citations to date
0
Altmetric
Appendix

Erratum

Page 1695 | Published online: 12 Nov 2013
This article refers to:
Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

Correction to: Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

Hawinkels LJAC, de Vinuesa AG & ten Dijke P. Expert Opin. Investig. Drugs 2013;22(11):1371-83

Following publication of this article, an error has been identified in the text. On page 1377, in section 1.7, the reference citation in the sentence “This indicates that BMP-10 can take over the role of BMP-9, as it also binds to ALK1-Fc [68].” is incorrect. The correct reference is given below:

Ricard N, Ciais D, Levet S, et al. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 2012;119:6162-71.

This is corrected in the online PDF and the sentence reads as follows:

This indicates that BMP-10 can take over the role of BMP-9, as it also binds to ALK1-Fc [88].

Reference:

[88] Ricard N, Ciais D, Levet S, et al. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 2012;119:6162-71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.